Il rapporto
Notizie verificate su finanziamenti, sedi centrali e leadership delle aziende più innovative al mondo
3,146 report e oltre
TytoCare Names Adam Pellegrini Chief Executive Officer
TytoCare named Adam Pellegrini Chief Executive Officer alongside a $25 million-plus growth round led by Insight Partners to scale its AI-first clinical enablement platform.
Anthropic raises $4B from Amazon in landmark AI safety deal
Amazon invests up to $4 billion in Anthropic, the AI safety startup behind Claude, marking one of the largest AI investments to date and reshaping the competitive landscape.
Inflection AI raises $1.3B at $4B valuation for Pi personal AI assistant
Inflection AI secured $1.3B led by Microsoft, Reid Hoffman, and Bill Gates at $4B valuation to build Pi—a kind, empathetic personal AI assistant. Microsoft later acquires most of the team in landmark AI talent deal.
World Labs raises $230M at $1B+ valuation for spatial AI and 3D world models
World Labs secures $230M led by Andreessen Horowitz at $1B+ valuation, as Fei-Fei Li's startup builds AI models that understand 3D space and physics, enabling machines to perceive and interact with the physical world like humans.
Harvey AI raises $100M Series C at $1.5B valuation for legal AI assistant
Harvey AI secures $100M Series C led by Kleiner Perkins at $1.5B valuation, deploying AI-powered legal research and drafting tools at Allen & Overy, PwC, and 100+ law firms globally.
Luma AI Raises $900 million in Series C
Luma AI, a AI Software company based in San Francisco CA, has raised $900 million in Series C at a $4 billion valuation led by HUMAIN.
Character.AI Raises $150M Series A
Conversational AI platform enabling users to create and interact with personalized AI characters for entertainment and productivity
Abridge Raises $250 Million in Series D - October 2024
Abridge announced $250 Million in Series D funding at a $2.5 Billion (Pre-Money) valuation. Abridge is a generative AI platform that converts medical conversations into clinically functional and billable documentation at the point of care, re...
Tempus AI Raises $200M Series G
Precision medicine company using AI and machine learning to analyze clinical and molecular data for personalized cancer treatment
Visualizzazione di 9 report • Pagina 1 • Categoria: all
Rimani avanti rispetto al mercato
Ricevi insight settimanali nella tua casella di posta. Niente spam, solo intelligenza.